Literature DB >> 1752978

Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

S V Polacarz1, J Darne, E G Sheridan, R Ginsberg, F Sharp.   

Abstract

The monoclonal antibody Myc 1-6E10 was used in an immunocytochemical technique to examine the expression of the c-myc oncogene in normal endocervices and those with glandular intraepithelial neoplasia and invasive malignancy. Eleven of 14 normal endocervical biopsy specimens did not express the gene, while three showed nuclear, or light basal cytoplasmic localisation of the gene product, or both. All but one of 14 cases of low and high grade glandular intraepithelial neoplasia, and all 17 cases of invasive adenocarcinoma, showed a pan-cellular pattern of immunostaining. Of considerable additional interest was the demonstration of field changes in morphologically normal glandular epithelium in those biopsy specimens with concurrent cervical glandular intraepithelial neoplasia or adenocarcinoma. This was manifest as increased concentrations of myc proteins compared with normal tissues. These results further support the role of the c-myc gene in oncogenesis, and in the light of field changes, suggest possible difficulties in the clinical management of this group of patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752978      PMCID: PMC496625          DOI: 10.1136/jcp.44.11.896

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  FOLLOW-UP OF PATIENTS WITH ADENOCARCINOMA OF THE CERVIX AND CERVICAL STUMP.

Authors:  C H PEETE; F B CARTER; W B CHERNY; R T PARKER
Journal:  Am J Obstet Gynecol       Date:  1965-10-01       Impact factor: 8.661

2.  Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms.

Authors:  A R Williams; J Piris; A H Wyllie
Journal:  J Pathol       Date:  1990-04       Impact factor: 7.996

3.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

4.  Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.

Authors:  H M Lachman; A I Skoultchi
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

5.  C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.

Authors:  G Riou; M Barrois; M G Lê; M George; V Le Doussal; C Haie
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

6.  Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia.

Authors:  J V Brown; W A Peters; D J Corwin
Journal:  Gynecol Oncol       Date:  1991-01       Impact factor: 5.482

7.  Increased incidence of adenocarcinoma of uterine cervix.

Authors:  J R Davis; L B Moon
Journal:  Obstet Gynecol       Date:  1975-01       Impact factor: 7.661

8.  c-myc Gene amplification in primary stomach cancer.

Authors:  T Koda; S Matsushima; A Sasaki; Y Danjo; M Kakinuma
Journal:  Jpn J Cancer Res       Date:  1985-07

9.  Oncogenes and germ cell tumours.

Authors:  K Sikora; G Evan; J Watson
Journal:  Int J Androl       Date:  1987-02

10.  Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ.

Authors:  T P Rollason; P Byrne; A Williams; G Brown
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

View more
  1 in total

1.  Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.

Authors:  J J O'Leary; R J Landers; M Crowley; I Healy; W F Kealy; J Hogan; C T Doyle
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.